Published in J Clin Diagn Res on August 01, 2016
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2013) 20.79
Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med (1998) 15.09
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Emerging epidemic of cardiovascular disease in developing countries. Circulation (1998) 6.41
High-density lipoprotein--the clinical implications of recent studies. N Engl J Med (1989) 5.70
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation (1997) 4.81
Burden of non-communicable diseases in South Asia. BMJ (2004) 4.19
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation (1990) 3.83
Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J (1996) 3.66
Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol (2001) 3.53
Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr (1996) 2.69
A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A (1997) 2.53
Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol (1997) 2.03
How to calculate sample size for different study designs in medical research? Indian J Psychol Med (2013) 1.95
The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocrinol Metab (2004) 1.60
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.56
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis (2004) 1.54
The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J Clin Endocrinol Metab (2004) 1.50
The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. Nutr Metab Cardiovasc Dis (2007) 1.46
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Coronary artery disease and its risk factors status in iran: a review. Iran Red Crescent Med J (2011) 1.43
Recent trends in coronary heart disease epidemiology in India. Indian Heart J (2009) 1.43
Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care (1998) 1.33
India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol (2007) 1.30
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb (1993) 1.24
Isolation and characterization of the human hepatic lipase gene. J Biol Chem (1990) 1.22
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res (2003) 1.15
Cardiovascular disease risk factors in Asian Indian population: A systematic review. J Cardiovasc Dis Res (2014) 1.10
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol (1998) 1.09
Coronary artery disease in Indians. Indian Heart J (2002) 1.07
Structure of the human hepatic triglyceride lipase gene. Biochemistry (1989) 1.06
The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res (2000) 1.03
Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open (2014) 0.99
The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis (2004) 0.99
Genomic approaches to coronary artery disease. Indian J Med Res (2010) 0.96
Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans (2003) 0.96
Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb (1993) 0.95
Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol (1997) 0.93
Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res (1997) 0.92
Profile of coronary artery disease in Indian women: correlation of clinical, non invasive and coronary angiographic findings. Indian Heart J (1991) 0.91
The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study. Nutr Metab Cardiovasc Dis (2007) 0.88
Third Meeting of the International Working Group on Coronary Artery Disease in South Asians. 29 March 1998, Atlanta, USA. Indian Heart J (1999) 0.87
Association between -250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population. Clin Genet (2004) 0.86
Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans. J Biochem Mol Biol (2003) 0.86
Quantitative assessment of the effect of hepatic lipase gene polymorphism on the risk of coronary heart disease. Arch Med Res (2010) 0.85
Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J Intern Med (2005) 0.84
Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients. J Diabetes Complications (2008) 0.84
G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol (2000) 0.84
Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response. Lipids Health Dis (2011) 0.83
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res (2005) 0.83
Hepatic lipase gene -514C/T polymorphism in the Guangxi Hei Yi Zhuang and Han populations. Lipids (2008) 0.82
The -250G-->A polymorphism in the human hepatic lipase gene promoter affects blood lipids in Chinese. Clin Chim Acta (2005) 0.81
Fat intake influences the effect of the hepatic lipase C-514T polymorphism on HDL-cholesterol levels in children. Exp Biol Med (Maywood) (2009) 0.81
Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis (1999) 0.80
Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab (2008) 0.80
The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment. Atherosclerosis (2005) 0.80
Association of the G-250A promoter polymorphism in the hepatic lipase gene with the risk of type 2 diabetes mellitus. Ann Endocrinol (Paris) (2013) 0.79
The -514C/T Polymorphism of Hepatic Lipase Gene among Iranian Patients with Coronary Heart Disease. Iran J Public Health (2012) 0.79
[Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2009) 0.79
Hepatic lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran. Eur J Cardiovasc Prev Rehabil (2006) 0.78
Association between -514C-->T polymorphism of the hepatic lipase gene and coronary artery disease in a Turkish population. Acta Cardiol (2008) 0.78
Lack of Association between Polymorphisms of Hepatic Lipase with Lipid Profile in Young Jordanian Adults. Lipid Insights (2014) 0.76
Cold pressor response in high landers versus low landers. J Clin Diagn Res (2014) 0.75